A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy

被引：0

作者：

Tristan D Yan ^{[1
]}

Christopher Qian Cao ^{[2
]}

Stine Munkholm-Larsen ^{[1
]}

机构：

[1] Department of Cardiothoracic Surgery,University of Sydney,Royal Prince Alfred Hospital

[2] Department of Surgery,John Hunter Hospital

来源：

World Journal of Gastrointestinal Oncology | 2010年 / 2卷 / 02期

关键词：

Intraperitoneal chemotherapy; Mitomycin C; Doxorubicin; Cisplatin; 5-fluorouracil; Paclitaxel; Peritoneal surface;

D O I：

暂无

中图分类号：

R735 [消化系肿瘤];

学科分类号：

100214 ;

摘要：

Perioperative intraperitoneal chemotherapy in combination with cytoreductive surgery has been shown to be of benefit for treating selected patients with peritoneal surface malignancy.It has become a new standard of care in the management of diffuse malignant peritoneal mesothelioma and peritoneal dissemination of appendiceal malignancy.Numerous recent publications on carcinomatosis from colorectal cancer and gastric cancer identify groups of patients that would benef it from this local-regional approach for prevention and treatment of carcinomatosis.This review focuses on pharmacological information regarding intraperitoneal chemotherapeutic agents commonly used in gastrointestinal oncology.

引用

页码：109 / 116

页数：8

共 25 条

[1] Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination [J].

de Bree, E. ;

Rosing, H. ;

Michalakis, J. ;

Romanos, J. ;

Relakis, K. ;

Theodoropoulos, P. A. ;

Beijnen, J. H. ;

Georgoulias, V. ;

Tsiftsis, D. D. .

EJSO, 2006, 32 (06) :666-670

[2] Neoadjuvant treatment of gastric cancer with peritoneal dissemination [J].

Yonemura, Y. ;

Bandou, E. ;

Sawa, T. ;

Yoshimitsu, Y. ;

Endou, Y. ;

Sasaki, T. ;

Sugarbaker, P. H. .

EJSO, 2006, 32 (06) :661-665

[3] Pharmacokinetic and phase II study of heated intraoperative intraperitoneal melphalan [J].

Sugarbaker, Paul H. ;

Stuart, O. Anthony .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (02) :151-155

[4] Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model [J].

Glehen, O ;

Stuart, OA ;

Mohamed, F ;

Sugarbaker, PH .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (01) :79-84

[5] Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma [J].

Shen, P ;

Hawksworth, J ;

Lovato, J ;

Loggie, BW ;

Geisinger, KR ;

Fleming, RA ;

Levine, EA .

ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) :178-186

[6]

Intraperitoneal chemotherapy with mitoxantrone in malignant ascites[J] . K.H. Link,M. Roitman,M. Holtappels,I. Runnebaum,H. Urbanzyk,G. Leder,L. Staib.Surgical Oncology Clinics of North America . 2003 (3)

[7]

A review of peritoneal mesothelioma at the Washington Cancer Institute[J] . Paul H Sugarbaker,Laura S Welch,Faheez Mohamed,Olivier Glehen.Surgical Oncology Clinics of North America . 2003 (3)

[8]

Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis[J] . Dominique M Elias,Lucas Sideris.Surgical Oncology Clinics of North America . 2003 (3)

[9] A comparison of hetastarch and peritoneal dialysis solution for intraperitoneal chemotherapy delivery [J].

Mohamed, F ;

Marchettini, P ;

Stuart, OA ;

Yoo, D ;

Sugarbaker, PH .

EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (03) :261-265

[10]

Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread[J] . C. Pablo Carmignani,Tessa A. Sugarbaker,Christina M. Bromley,Paul H. Sugarbaker.Cancer and Metastasis Reviews . 2003 (4)

← 1 2 3 →